BeStock  
Stocks › GLUE

Monte Rosa Therapeutics GLUE

US equityMarket cap rank #3349
$8.64 −$0.27 (-3.03%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $8.64 0.00%
Open$8.73
Prev close$8.91
Day range$8.48 – $9.04
Volume2.52M
Market cap$738.29M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.7x
CheapRich

Near the bottom of its 5-year range · 11th percentile, 5-year average 2.6x

Price / book1.6x
CheapRich

Around its usual level · 54th percentile, 5-year average 2.0x

#2639 of 5329 stocks by PB (1 = cheapest)

Price / sales11.4x
CheapRich

Above its usual level · 71st percentile, 5-year average 22.3x

#4550 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-51x-6x40x85xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$19.42
Price vs. fair value-55.5%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.61 – 2.03 54% (pricier than usual) #2639 of 5329 (1 = cheapest)
PE -6.74 -3.82 2.60 11% (cheaper than usual) –
PS 11.39 17.95 22.26 71% (pricier than usual) #4550 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on GLUE.

Sign in to join the discussion.

Scroll to Top